These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 28814568

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evidence for hepatocellular differentiation in alpha-fetoprotein-negative gastric adenocarcinoma with hepatoid morphology: a study with in situ hybridisation for albumin mRNA.
    Supriatna Y, Kishimoto T, Uno T, Nagai Y, Ishikura H.
    Pathology; 2005 Jun; 37(3):211-5. PubMed ID: 16175893
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma.
    Osada M, Aishima S, Hirahashi M, Takizawa N, Takahashi S, Nakamura K, Tanaka M, Maehara Y, Takayanagi R, Oda Y.
    Hum Pathol; 2014 Jun; 45(6):1243-50. PubMed ID: 24767858
    [Abstract] [Full Text] [Related]

  • 6. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
    Ushiku T, Shinozaki A, Shibahara J, Iwasaki Y, Tateishi Y, Funata N, Fukayama M.
    Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Metastatic gastrointestinal hepatoid adenocarcinoma of the liver: a high-grade carcinoma that is easily confused with primary hepatocellular carcinoma].
    Lou KX, Fu Y, Wu HY, Wang T, Kwasi ASD, Fan XS.
    Zhonghua Bing Li Xue Za Zhi; 2020 Jul 08; 49(7):710-714. PubMed ID: 32610383
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature.
    Haninger DM, Kloecker GH, Bousamra Ii M, Nowacki MR, Slone SP.
    Mod Pathol; 2014 Apr 08; 27(4):535-42. PubMed ID: 24030743
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Carcinoma of the stomach with hepatocyte differentiation (hepatoid adenocarcinoma).
    Roberts CC, Colby TV, Batts KP.
    Mayo Clin Proc; 1997 Dec 08; 72(12):1154-60. PubMed ID: 9413299
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
    Murakami T, Yao T, Mitomi H, Morimoto T, Ueyama H, Matsumoto K, Saito T, Osada T, Nagahara A, Watanabe S.
    Gastric Cancer; 2016 Apr 08; 19(2):498-507. PubMed ID: 25893262
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types.
    Fujimoto M, Matsuzaki I, Nishino M, Iwahashi Y, Warigaya K, Kojima F, Ono K, Murata SI.
    J Clin Pathol; 2018 Jul 08; 71(7):600-607. PubMed ID: 29305518
    [Abstract] [Full Text] [Related]

  • 20. Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation.
    Ward SC, Huang J, Tickoo SK, Thung SN, Ladanyi M, Klimstra DS.
    Mod Pathol; 2010 Sep 08; 23(9):1180-90. PubMed ID: 20495535
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.